3EO: (4R,6S,7Z,15S,17S)-17-[({7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)methyl]-13-methyl-N-[(1-methylcyclopropyl)sulfonyl]-2,14-dioxo-1,3,13-triazatricyclo[13.2.0.0~4,6~]heptadec-7-ene-4-carboxamide
3EO is a Ligand Of Interest in 4TYD designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4TYD_3EO_C_302 | 64% | 7% | 0.167 | 0.966 | 2.25 | 2.51 | 11 | 21 | 3 | 0 | 100% | 1 |
4TYD_3EO_F_302 | 63% | 9% | 0.169 | 0.966 | 2.26 | 2.27 | 11 | 21 | 4 | 0 | 100% | 1 |
4TYD_3EO_D_302 | 63% | 7% | 0.176 | 0.972 | 2.3 | 2.43 | 11 | 21 | 4 | 0 | 100% | 1 |
4TYD_3EO_H_302 | 63% | 7% | 0.175 | 0.97 | 2.28 | 2.51 | 12 | 20 | 3 | 0 | 100% | 1 |
4TYD_3EO_E_302 | 62% | 8% | 0.18 | 0.974 | 2.25 | 2.38 | 12 | 19 | 4 | 0 | 100% | 1 |
4TYD_3EO_A_302 | 60% | 8% | 0.181 | 0.969 | 2.31 | 2.28 | 11 | 17 | 4 | 0 | 100% | 1 |
4TYD_3EO_B_302 | 60% | 7% | 0.187 | 0.973 | 2.28 | 2.47 | 12 | 20 | 3 | 0 | 100% | 1 |
4TYD_3EO_G_302 | 57% | 7% | 0.2 | 0.976 | 2.29 | 2.53 | 11 | 21 | 2 | 0 | 100% | 1 |
4TYD_3EO_M_302 | 56% | 8% | 0.177 | 0.951 | 2.24 | 2.41 | 13 | 22 | 4 | 0 | 100% | 1 |
4TYD_3EO_K_302 | 50% | 7% | 0.187 | 0.939 | 2.3 | 2.52 | 12 | 21 | 2 | 0 | 100% | 1 |
4TYD_3EO_J_302 | 48% | 8% | 0.203 | 0.949 | 2.24 | 2.45 | 11 | 22 | 5 | 0 | 100% | 1 |
4TYD_3EO_L_302 | 48% | 8% | 0.206 | 0.949 | 2.33 | 2.39 | 12 | 21 | 3 | 0 | 100% | 1 |